The ANKK1 gene associated with addictions is expressed in astroglial cells and upregulated by apomorphine.
paper
Cited
Public
Unavailable
- Authors
- Hoenicka, Janet; Quiñones-Lombraña, Adolfo; España-Serrano, Laura; Alvira-Botero, Ximena; Kremer, Leonor; Pérez-González, Rocío; Rodríguez-Jiménez, Roberto; Jiménez-Arriero, Miguel Angel; Ponce, Guillermo; Palomo, Tomás
- Year
- 2010
- Journal
- Biological psychiatry
- PMID
- 19853839
- DOI
- 10.1016/j.biopsych.2009.08.012
BACKGROUND: TaqIA, the most widely analyzed genetic polymorphism in addictions, has traditionally been considered a gene marker for association with D2 dopamine receptor gene (DRD2). TaqIA is located in the coding region of the ANKK1 gene that overlaps DRD2 and encodes a predicted kinase ANKK1. The ANKK1 protein nonetheless had yet to be identified. This study examined the ANKK1 expression pattern as a first step to uncover the biological bases of TaqIA-associated phenotypes. METHODS: Northern blot and quantitative reverse-transcriptase polymerase chain reaction analyses were performed to analyze the ANKK1 mRNA. To study ANKK1 protein expression, we developed two polyclonal antibodies to a synthetic peptides contained in the putative Ser/Thr kinase domain. RESULTS: We demonstrate that ANKK1 mRNA and protein were expressed in the adult central nervous system (CNS) in human and rodents, exclusively in astrocytes. Ankk1 mRNA level in mouse astrocyte cultures was upregulated by apomorphine, suggesting a potential relationship with the dopaminergic system. Developmental studies in mice showed that ANKK1 protein was ubiquitously located in radial glia in the CNS, with an mRNA expression pick around embryonic Day 15. This time expression pattern coincided with that of the Drd2 mRNA. On induction of differentiation by retinoic acid, a sequential expression was found in human neuroblastoma, where ANKK1 was expressed first, followed by that of DRD2. An opposite time expression pattern was found in rat glioma. CONCLUSIONS: Spatial and temporal regulation of the expression of ANKK1 suggest an involvement of astroglial cells in TaqIA-related neuropsychiatric phenotypes both during development and adult life.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Disordered eating in early childhood: DRD2 and COMT gene polymorphisms and behavioral features in family trios. | Pascale E et al. | — | 2026 | → |
| Detection of positive selection on depression-associated genes. | Yang S et al. | — | 2025 | → |
| ANKK1 Is a Wnt/PCP Scaffold Protein for Neural F-ACTIN Assembly. | Domínguez-Berzosa L et al. | — | 2024 | → |
| Cortical and Striatal Astrocytes of Neonatal Rats Display Distinct Molecular and Pharmacological Characteristics of Dopamine Uptake. | Sočan V et al. | — | 2024 | → |
| Kinetic Properties and Pharmacological Modulation of High- and Low-Affinity Dopamine Transport in Striatal Astrocytes of Adult Rats. | Sočan V et al. | — | 2024 | → |
| Molecular and Environmental Determinants of Addictive Substances. | Lorek M et al. | — | 2024 | → |
| Relationship of Genetic Polymorphisms and Microbial Composition with Binge Eating Disorder: A Systematic Review. | Monserrat Hernández M et al. | — | 2024 | → |
| Association Between DRD2 and DRD4 Polymorphisms and Eating Disorders in an Italian Population. | Ceccarini MR et al. | — | 2022 | → |
| Association between DRD2/ANKK1 TaqIA Allele Status and Striatal Dopamine D2/3 Receptor Availability in Alcohol Use Disorder. | Spitta G et al. | — | 2022 | → |
| <i>Ankk1</i> Loss of Function Disrupts Dopaminergic Pathways in Zebrafish. | Leggieri A et al. | — | 2022 | → |
| Genetic diversity of the North African population revealed by the typing of SNPs in the DRD2/ANKK1 genomic region. | Mestiri S et al. | — | 2021 | → |
| Motivational learning biases are differentially modulated by genetic determinants of striatal and prefrontal dopamine function | Richter A et al. | — | 2021 | — |
| Motivational learning biases are differentially modulated by genetic determinants of striatal and prefrontal dopamine function. | Richter A et al. | — | 2021 | → |
| Regulatory rare variants of the dopaminergic gene ANKK1 as potential risk factors for Parkinson's disease. | Pérez-Santamarina E et al. | — | 2021 | → |
| Ankyrin Repeat and Kinase Domain Containing 1 Gene, and Addiction Vulnerability. | Koeneke A et al. | — | 2020 | → |
| Comorbid HIV infection and alcohol use disorders: Converging glutamatergic and dopaminergic mechanisms underlying neurocognitive dysfunction. | Giacometti LL et al. | — | 2019 | → |
| The influence of SLC6A3 and DRD2 polymorphisms on levodopa-therapy in patients with sporadic Parkinson's disease. | Dos Santos EUD et al. | — | 2019 | → |
| A 35.8 kilobases haplotype spanning ANKK1 and DRD2 is associated with heroin dependence in Han Chinese males. | Zhang J et al. | — | 2018 | → |
| ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | Rubio-Solsona E et al. | — | 2018 | → |
| DRD2: Bridging the Genome and Ingestive Behavior. | Sun X et al. | — | 2017 | → |
| The Addiction-Related Protein ANKK1 is Differentially Expressed During the Cell Cycle in Neural Precursors. | España-Serrano L et al. | — | 2017 | → |
| The genetic epidemiology of substance use disorder: A review. | Prom-Wormley EC et al. | — | 2017 | → |
| Dietary triglycerides as signaling molecules that influence reward and motivation. | Berland C et al. | — | 2016 | → |
| Genetic variation and dopamine D2 receptor availability: a systematic review and meta-analysis of human in vivo molecular imaging studies. | Gluskin BS et al. | — | 2016 | → |
| Genetic variation and the D2 dopamine receptor: implications for the treatment of neuropsychiatric disease. | Mickey BJ | — | 2016 | → |
| Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status. | Eisenstein SA et al. | — | 2016 | → |
| Specific Reaction Patterns to Distinct Positive Emotional Cues Related to Incentive Motivation in Dependence of the Taq1A-Polymorphism: Molecular Genetic Associations of Early and Late Event-Related Potentials. | Munk AJ et al. | — | 2016 | → |
| The Addiction-Related Gene Ankk1 is Oppositely Regulated by D1R- and D2R-Like Dopamine Receptors. | Ponce G et al. | — | 2016 | → |
| Association of a common genetic variant within ANKK1 with six-month cognitive performance after traumatic brain injury. | Yue JK et al. | — | 2015 | → |
| Common single nucleotide variants underlying drug addiction: more than a decade of research. | Bühler KM et al. | — | 2015 | → |
| Overlapping dopaminergic pathway genetic susceptibility to heroin and cocaine addictions in African Americans. | Levran O et al. | — | 2015 | → |
| The addiction-related gene ANKK1 in Parkinsonian patients with impulse control disorder. | Hoenicka J et al. | — | 2015 | → |
| The ANKK1/DRD2 locus is a genomic substrate for affective priming and recognition of angry faces. | Koeneke A et al. | — | 2015 | → |
| The significant association of Taq1A genotypes in DRD2/ANKK1 with smoking cessation in a large-scale meta-analysis of Caucasian populations. | Ma Y et al. | — | 2015 | → |
| Updated findings of the association and functional studies of DRD2/ANKK1 variants with addictions. | Ma Y et al. | — | 2015 | → |
| Dopaminergic pathway polymorphisms and heroin addiction: further support for association of CSNK1E variants. | Levran O et al. | — | 2014 | → |
| Genetics of alcohol dependence: a review of clinical studies. | Samochowiec J et al. | — | 2014 | → |
| Parkinson's disease pharmacogenomics: new findings and perspectives. | Schumacher-Schuh AF et al. | — | 2014 | → |
| Screening and functional analysis of glioma‑related genes induced by candoxin. | Qiu L et al. | — | 2014 | → |
| ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse. | Spellicy CJ et al. | — | 2013 | → |
| ANKK1, TTC12, and NCAM1 polymorphisms and heroin dependence: importance of considering drug exposure. | Nelson EC et al. | — | 2013 | → |
| Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction. | Levran O et al. | — | 2013 | → |
| Linguistic grammar learning and DRD2-TAQ-IA polymorphism. | Wong PC et al. | — | 2013 | → |
| Motivational salience and genetic variability of dopamine D2 receptor expression interact in the modulation of interference processing. | Richter A et al. | — | 2013 | → |
| Strategies for repair of white matter: influence of osmolarity and microglia on proliferation and apoptosis of oligodendrocyte precursor cells in different basal culture media. | Kleinsimlinghaus K et al. | — | 2013 | → |
| The TaqIA RFLP is associated with attenuated intervention-induced body weight loss and increased carbohydrate intake in post-menopausal obese women. | Cameron JD et al. | — | 2013 | → |
| DRD2 haplotype is associated with dyskinesia induced by levodopa therapy in Parkinson's disease patients. | Rieck M et al. | — | 2012 | → |
| Genetics of dopamine receptors and drug addiction. | Gorwood P et al. | — | 2012 | → |
| Influence of DRD2 and ANKK1 polymorphisms on the manifestation of withdrawal syndrome symptoms in alcohol addiction. | Grzywacz A et al. | — | 2012 | → |
| The anticonvulsant levetiracetam potentiates alcohol consumption in non-treatment seeking alcohol abusers. | Mitchell JM et al. | — | 2012 | → |
| Unraveling the ischemic brain transcriptome in a permanent middle cerebral artery occlusion mouse model by DNA microarray analysis. | Hori M et al. | — | 2012 | → |
| PharmGKB summary: dopamine receptor D2. | Mi H et al. | — | 2011 | → |
| Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood. | Nemoda Z et al. | — | 2011 | → |
| The ANKK1 protein associated with addictions has nuclear and cytoplasmic localization and shows a differential response of Ala239Thr to apomorphine. | Garrido E et al. | — | 2011 | → |
| The role of dopamine transporter (SLC6A3) and dopamine D2 receptor/ankyrin repeat and kinase domain containing 1 (DRD2/ANKK1) gene polymorphisms in personality traits. | Kazantseva A et al. | — | 2011 | → |
| A genetic schizophrenia-susceptibility region located between the ANKK1 and DRD2 genes. | Dubertret C et al. | — | 2010 | → |
| Epigenetics and biomarkers in the staging of neuropsychiatric disorders. | Archer T et al. | — | 2010 | → |